Revamping snow clearing, sidewalk repair on the docket for Edmonton city committee
City administration will present options to the committee, detailed in a public report, including proactively repairing sidewalks and getting more snow plows on the road.
If committee receives the report for information — which is Administration's recommended action — Administration will continue with option one, which it says will reprioritize resources without impacting the budget.
Option one would aim to clear "high social vulnerability areas" earlier.
Other options could include adding various numbers of equipment, sidewalk repair and staff.
The total budget for snow and ice control is $67 million each year.
As Edmonton has grown, so too has the total length of public sidewalks, with a increase of eight per cent over the past 10 years.
In 2022, a high priority sidewalk index was created for each sidewalk block in Edmonton and looks at various factors.
These include pedestrian volume, proximity to places like schools, senior centres, high frequency bus stops, as well as the social vulnerability index, which looks at how various populations in Edmonton rely on sidewalk access.
Those factors are part of the process in making recommendations to committee, administration said.
Both sidewalk maintenance and enforcement services would retain their existing model under option one, which administration would pursue if the committee recommends it.
The city manages close to 5,776 kilometres of public sidewalks with a $5.9 million annual operating budget dedicated to sidewalk maintenance, while minor and major capital renewals are funded separately.
The report, and other options, will be presented to the community and public services committee on Aug. 11 where councillors will vote on whether to recommend changes to all of city council.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment
Bausch Health Companies Inc. (NYSE:BHC) is one of the most undervalued Canadian stocks to buy now. On July 29, Bausch Health Companies announced a definitive agreement to acquire DURECT Corporation (NASDAQ:DRRX). The acquisition is valued at ~$63 million upfront with potential for an additional $350 million in sales milestone payments, and will be an all-cash transaction. Bausch Health is acquiring DURECT primarily for its lead asset, called larsucosterol. This novel therapeutic molecule is an epigenetic modulator that the FDA has granted Breakthrough Therapy Designation for the treatment of alcoholic hepatitis/AH, which is a life-threatening form of alcohol-associated liver disease. A closeup of pills in a pharmacy, representing the high quality medications of the company. AH is characterized by severe liver inflammation & necrosis and accounted for ~164,000 hospital admissions in the US in 2021. There are currently no FDA or European Medicines Agency/EMA-approved treatments for the condition. The acquisition of larsucosterol strengthens Bausch Health's commitment to hepatology. Bausch Health plans to use its expertise to advance larsucosterol through a planned Phase 3 program. Bausch Health Companies Inc. (NYSE:BHC) is a diversified specialty pharmaceutical and medical device company that develops, manufactures, and markets products in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, OTC products, aesthetic medical devices, and eye health. DURECT Corporation (NASDAQ:DRRX) is a late-stage biopharmaceutical company that develops epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, such as acute organ injury. While we acknowledge the potential of BHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
15 minutes ago
- Yahoo
Osisko Development (ODV) Secures $450 Million Financing for Cariboo Gold Project
Osisko Development Corp. (NYSE:ODV) is one of the best Canadian gold stocks to buy according to hedge funds. On July 21, the company announced that it had secured a $450 million project loan facility from Appian Capital Advisory. The funds will be used to facilitate the development and construction of the Cariboo Gold Project in central British Columbia, Canada. Photo by Gold-bar-jingming-pan on Unsplash The financing facility is structured in two parts. $100 million was drawn on the day of the announcement, and subsequent draws will be done in four tranches, totaling $350 million. The initial sum will be used for a 13,000-meter infill drilling campaign to improve mine planning, pre-construction and construction activities for Cariboo, repayment of an existing $25 million term loan with National Bank of Canada (maturing in October 2025), and as general working capital for the project. The subsequent draws will be available over the next 36 months, contingent on the achievement of project milestones and meeting customary conditions. Cariboo Gold is a permitted project, with required environmental and mining permits in place as of late 2024. Osisko owns 100% rights to the project. Osisko Development Corp. (NYSE:ODV) is a Canadian gold development company. It explores, develops, and operates high-grade gold projects, with its flagship Cariboo Gold Project located in British Columbia. The Cariboo site spans a historic district and is designed for underground mining and ore sorting, targeting sustainable and scalable production. Osisko's main product is gold bullion, derived from ongoing drilling and feasibility-stage development activities. While we acknowledge the potential of ODV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Top 10 Medical AI Companies to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
Gold Royalty (GROY) Reports Record Q2 Revenue Up 100% Year-Over-Year
Gold Royalty Corp. (NYSE:GROY) is one of the best Canadian gold stocks to buy according to hedge funds. On July 24, the company announced Q2 2025 earnings, in which it reported record revenue. The total revenue, land agreement proceeds and interest in the quarter increased by approximately 100% year-over-year, reaching $4.4 million. Direct revenues from royalties totaled $3.8 million. Menna/ Also during the quarter, the gold equivalent ounces (GEOs) totaled 1,346 GEOs. For the first six months of 2025, total revenue climbed 25% year-over-year to a record $8.0 million (revenue of $6.9 million), corresponding to 2,595 GEOs. The company credits the increase in revenue to continued strong commodity prices and production growth from its key royalty interests at several operations, including Canadian Malartic, Borborema, and Borden (Porcupine). Gold Royalty reaffirmed its full-year 2025 production forecast of 5,700 to 7,000 GEOs. The company noted that production is expected to be concentrated more heavily in the second half of the year as newly started mining operations, including Côté, Vareš, and Borborema, ramp up toward full-scale production. Gold Royalty Corp. (NYSE:GROY) is a Vancouver-based precious metals-focused royalty company. It provides financing to gold mining firms by acquiring royalties, streams, and similar interests across various stages of mine development. The company's operations are sustained by gold-linked royalty income, generated from agreements with active and near-production mines throughout North America. While we acknowledge the potential of GROY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Top 10 Medical AI Companies to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data